Men with low PSA levels (<1.5 ng/mL) in the first screening round will only be offered retesting in a third screening round (at 6 years after initial screening), so the long-term cancer detection rate in prostate cancer screening remains to be shown. The gene discussed is KLK3; the disease is cancer.